Tetragenetics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tetragenetics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10572
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tetragenetics Inc (Tetragenetics) is a biotechnology company that discovers and develops therapeutics for autoimmune disease and pain. The company develops antibodies for autoimmune disorders, pains and other. Its autoimmune disorders include Type 1 Diabetes Mellitus, rheumatoid arthritis, multiple sclerosis, psoriasis, lupus and others. The company’s drug developing technologies comprise ion channels, tetraexpress, and antibody discovery. Tetragenetics has partnered with various companies for drug discovery. The company provides drug discovery and development programs channels included in pathogenesis of autoimmunity and pain. Tetragenetics is headquartered in Arlington, Massachusetts, the US.

Tetragenetics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetragenetics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tetragenetics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
TetraGenetics Raises Funds through Venture Financing 11
Tetragenetics Raises USD1 Million in Venture Financing 12
Tetragenetics Raises USD0.3 Million in Financing Round 13
Tetragenetics Raises US$0.5 Million In Venture Financing 14
Tetragenetics Raises US$3 Million In Venture Financing 15
Partnerships 16
Tetragenetics Enters into Agreement with LifeArc 16
Tetragenetics Enters into Partnership with Modiquest Research 17
Tetragenetics Enters into Agreement with Theranyx 18
Tetragenetics Enters into Agreement with arGEN-X, Crystal Biosciences and Sevion Therapeutics 19
Tetragenetics Enters into Agreement with MedImmune for Drug Discovery Program 20
Licensing Agreements 21
Tetragenetics Enters Into Option For Licensing Agreement With Pfizer For SionX Technology 21
Tetragenetics Enters Into Licensing Agreement With Amgen For Antibodies 22
Tetragenetics Inc – Key Competitors 23
Tetragenetics Inc – Key Employees 24
Tetragenetics Inc – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Tetragenetics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetragenetics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetragenetics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Tetragenetics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TetraGenetics Raises Funds through Venture Financing 11
Tetragenetics Raises USD1 Million in Venture Financing 12
Tetragenetics Raises USD0.3 Million in Financing Round 13
Tetragenetics Raises US$0.5 Million In Venture Financing 14
Tetragenetics Raises US$3 Million In Venture Financing 15
Tetragenetics Enters into Agreement with LifeArc 16
Tetragenetics Enters into Partnership with Modiquest Research 17
Tetragenetics Enters into Agreement with Theranyx 18
Tetragenetics Enters into Agreement with arGEN-X, Crystal Biosciences and Sevion Therapeutics 19
Tetragenetics Enters into Agreement with MedImmune for Drug Discovery Program 20
Tetragenetics Enters Into Option For Licensing Agreement With Pfizer For SionX Technology 21
Tetragenetics Enters Into Licensing Agreement With Amgen For Antibodies 22
Tetragenetics Inc, Key Competitors 23
Tetragenetics Inc, Key Employees 24

List of Figures
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tetragenetics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tetragenetics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tetragenetics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SK Hynix Inc.:企業の戦略・SWOT・財務情報
    SK Hynix Inc. - Strategy, SWOT and Corporate Finance Report Summary SK Hynix Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Clarion Co., Ltd. (6796):企業の財務・戦略的SWOT分析
    Clarion Co., Ltd. (6796) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Optiscan Imaging Limited (OIL):製品パイプライン分析
    Summary Optiscan Imaging Limited (Optiscan) is a technology and product development company. It focuses on the development and application of microscopic imaging technologies for medical procedures. The company’s key product is ViewnVivo, a miniaturized fluorescence endo-microscope platform that bri …
  • UCB SA (UCB):企業の財務・戦略的SWOT分析
    UCB SA (UCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • National Electric Power Co:企業の戦略的SWOT分析
    National Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • FleetCor Technologies, Inc.:企業のM&A・事業提携・投資動向
    FleetCor Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FleetCor Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • TEGNA Inc (TGNA):企業の財務・戦略的SWOT分析
    TEGNA Inc (TGNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Purity Wholesale Grocers Inc:企業の戦略的SWOT分析
    Purity Wholesale Grocers Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Innovation Pharmaceuticals Inc (IPIX):製薬・医療:M&Aディール及び事業提携情報
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp, is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company provides pipeline products such as kevetr …
  • StormGeo AS:石油・ガス:M&Aディール及び事業提携情報
    Summary StormGeo AS (StormGeo) is a weather forecast company that offers professional weather services and decision support for weather sensitive operations. The company operates through segments that include shipping, oil and gas, marine operations, renewable, aviation, cross industry and media. It …
  • First Republic Bank:企業のM&A・事業提携・投資動向
    First Republic Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Republic Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Global Voice Group SA:企業の戦略的SWOT分析
    Global Voice Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sim Lian Group Ltd:企業の戦略・SWOT・財務情報
    Sim Lian Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Sim Lian Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Translate Bio Inc (TBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides (oligos) are molecules designed to …
  • Nakanishi Inc (7716):企業の財務・戦略的SWOT分析
    Nakanishi Inc (7716) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Analyticon Biotechnologies AG:企業の製品パイプライン分析2018
    Summary Analyticon Biotechnologies AG (Analyticon), a subsidiary of Analyticon Discovery GmbH, is a medical device company that develops, manufactures, and distributes diagnostic systems. The company provides products in the areas of urine diagnostics, clinical chemistry, coagulation, and hematology …
  • Glaukos Corp (GKOS):企業の財務・戦略的SWOT分析
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Cardno Ltd:企業のM&A・事業提携・投資動向
    Cardno Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cardno Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Thai Oil Public Co Ltd (TOP):石油・ガス:M&Aディール及び事業提携情報
    Summary Thai Oil Public Company Limited (Thai Oil), a subsidiary of PTT Public Company Limited, is an integrated energy company. It is one of the largest independent petroleum refineries and suppliers of petroleum products in Thailand. It operates the largest single-site refinery in the Chonburi pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆